drugset / Trial / NCT00438152
Lopinavir Capsules to Kaletra or Invirase Tablets
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will compare the benefit for patients switching from Kaletra® to Invirase® tablets over remaining on Kaletra® (based on randomization), to elicit the lipid benefits inferred in previous studies
Timeline
- Start
- 2006-09
- Primary completion
- 2009-02
- Completion
- 2009-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lopinavir | Other / unclassified | 400 mg | — |
| Comparator | Saquinavir | Small molecule | 1000 mg | — |
| Comparator | Ritonavir | Other / unclassified | 100 mg | — |